Impairment of left atrial function following pulsed-field ablation for persistent atrial fibrillation.

12 April 2026 (08:00 - 15:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Marek Hozman

Faculty Hospital Kralovske Vinohrady, Prague (Czechia)

6 More presentations in this session

Presentation thumbnail

Postoperative atrial fibrillation: function over fibrosis, prevention needed

Professor H. Wang (Shenyang, CN)

Abstract Slides Video

Presentation thumbnail

Recent trends and future projections in atrial fibrillation epidemiology: a european population-based study

Doctor J. Rodriguez Garcia (Hospitalet De Llobregat, ES)

Abstract Slides Video

Presentation thumbnail

Subclinical atrial fibrillation and the risk of heart failure: insights from ARTESiA

Doctor M. Frausing (Aarhus, DK)

Abstract Slides Video

Presentation thumbnail

Comparative 1-year outcomes of dofetilide vs amiodarone for atrial fibrillation in hypertrophic cardiomyopathy: a propensity-matched study

Doctor A. Okunlola (Boston, GB)

Abstract Slides Video

Presentation thumbnail

Heart failure over time in patients with screening detected atrial fibrillation - a postdoc analysis of the STROKESTOP and STROKESTOP II studies

Doctor G. Sado (Stockholm, SE)

Abstract Slides Video

Access the full session

Session thumbnail

Atrial fibrillation miscellaneous

The Event

Event poster

EHRA 2026

12 April - 14 April 2026

You may be interested in

Congress Presentation

Pulsed-field ablation does not lead to left atrial function impairment following pulmonary vein isolation compared with thermal ablation

Congress Session

Atrial fibrillation catheter ablation (2)

Congress Presentation

Impact of pulsed field versus cryoballoon ablation on left atrial function and stiffness in paroxysmal atrial fibrillation

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources